Name | BCL6-IN-3 |
---|
Description | BCL6-IN-3 (example 20a) is a B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity, extracted from patent WO2018215801A1. BCL6-IN-3 (example 20a) exhibits a GI50 of 70 nM in SU-DHL4 cells[1]. |
---|---|
Related Catalog | |
Target |
GI50: 70 nM (SU-DHL4 cells proliferation)[1]. |
References |
[1]. Benjamin Richard, et al. BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6. Patent. WO2018215801A1. |
Molecular Formula | C24H31ClF2N6O2 |
---|---|
Molecular Weight | 508.99 |